– Early diagnosis through genetic testing may lead to improved long-term outcomes for patients with neurotransmitter disorders, including AADC deficiency – SOUTH PLAINFIELD, N.J., Sept. 9, 2020 – PTC ...

SOUTH PLAINFIELD, N.J., Nov. 18, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of a no-cost testing program for aromatic L-amino acid decarboxylase (AADC) ...

SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who ...

It’s a testing afternoon for investors who placed bets on Translarna, a drug for a rare form of muscular dystrophy. Shares in PTC Therapeutics, a small biotech group which is developing the medicine, ...

2018 or 2020, whatever the case may be, isn’t very far off. According to a Positive Train Control implementation chart published on the Federal Railroad Administration website, 30 out 37 U.S. freight ...

BALTIMORE — Following a competitive procurement process, Professional Testing Corporation ® (PTC) has selected Prometric ® as their partner for the global administration of PTC client programs. Under ...

SOUTH PLAINFIELD, N.J., Sept. 9, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new program that provides genetic testing and counseling for people who may have a ...